TUESDAY, Feb. 13 (HealthDay News) — Two of the most common pregnancy complications for women, high blood pressure and gestational diabetes, could jeopardize the future heart health of their children, a new study suggests. Researchers found that the children of women who developed either or both of those conditions duringContinue Reading
FRIDAY, Feb. 2, 2024 (HealthDay News) — Women are much more prone than men to develop autoimmune diseases like rheumatoid arthritis, multiple sclerosis and lupus. Now, researchers have come up with a potential explanation for that — one that’s rooted in genes that drive a person’s gender. The female bodyContinue Reading
FRIDAY, Jan. 19, 2024 (HealthDay News) — Folks who drop pounds to help control their diabetes receive other substantial heath benefits for all their efforts, a new study says. Substantial weight loss that led to even a short-lived remission in type 2 diabetes also prompted a 40% lower rate inContinue Reading
THURSDAY, Jan. 4, 2024 (HealthDay News) — The U.S. Food and Drug Administration is investigating reports of additional dangers linked to several wildly popular weight-loss drugs. In a quarterly report issued this week, the agency said it is investigating cases of hair loss; aspiration (when food or other objects get into theContinue Reading
TUESDAY, Jan. 2, 2024 (HealthDay News) — Managing diabetes will be a less expensive proposition for more Americans in 2024. Sanofi has officially joined Novo Nordisk and Eli Lilly in lowering the cost of insulin to $35 a month for many patients. The three drugmakers are also drastically lowering the listContinue Reading
WEDNESDAY, Dec. 27, 2023 (HealthDay News) — It may not take as strict a diet as thought to keep type 1 diabetes under control: New Swedish research shows that a moderate low-carb diet still helped people with type 1 diabetes stick to blood-sugar targets. “The study shows that a moderateContinue Reading
THURSDAY, Dec. 21, 2023 (HealthDay News) — Kids who’ve survived cancer face many health challenges, and a heightened risk for diabetes is one of them, new research shows. A team at St. Jude’s Children’s Hospital in Memphis, Tenn., reports that these children have twice the odds of developing prediabetes (aContinue Reading
WEDNESDAY, Dec. 13, 2023 (HealthDay News) — A healthy plant-based diet can reduce a person’s risk of type 2 diabetes by 24%, a new study has found. Eating plenty of fresh fruits, vegetables and whole grains has this protective effect even in people with a genetic predisposition for diabetes orContinue Reading
TUESDAY, Dec. 12, 2023 (HealthDay News) — Many Americans battling diabetes are turning to a new class of injected drugs that includes blockbusters like Ozempic (semaglutide) and Mounjaro (tirzepatide). But a new study finds half of patients who use these “second line” therapies — a class called GLP-1 RAs — quitContinue Reading
TUESDAY, Dec. 11, 2023 (HealthDay News) — The diabetes and weight-loss drug Ozempic does not appear to harm a developing fetus when taken by pregnant women, a new study reports. Researchers found no elevated risk of birth defects among newborns of women who took medications to control their type 2Continue Reading
MONDAY, Dec. 11, 2023 (HealthDay News) — Folks who take the blockbuster weight-loss med tirzepatide (Zepbound) may regain much of the weight they lost soon after discontinuing it, new research shows. A trial funded by Eli Lilly, the injected drug’s maker, found that “in patients with obesity or overweight, withdrawingContinue Reading
FRIDAY, Dec. 8, 2023 (HealthDay News) — Could blockbuster diabetes and weight-loss meds such as Ozempic, Wegovy, Mounjaro and Zepbound also lower users’ odds for colon cancer? New research suggests they might. All of these medications (and more) fall into a class of diabetes drugs known as glucagon-like peptide-1 receptorContinue Reading
THURSDAY, Dec. 7, 2023 (HealthDay News) — A drug long used to curb rheumatoid arthritis may be a potent foe against another immune disorder, type 1 diabetes. Australian researchers report that baricitinib (Olumiant) appears to help patients newly diagnosed with type 1 diabetes maintain their natural ability to produce insulin,Continue Reading
WEDNESDAY, Dec. 6, 2023 (HealthDay News) — Girls whose periods begin before the age of 13 are at higher risk of becoming adult women with diabetes, compared to girls who start menstruation later, new research shows. An earlier onset of periods also appears to hike a woman’s odds for strokeContinue Reading